Author: Wisdom Bassey

Stevens-Johnson syndrome (SJS) is an uncommon yet severe condition affecting the skin and mucous membranes. Typically triggered by medication, it initiates with flu-like symptoms and progresses to a painful rash characterized by spreading and blistering. Subsequently, the affected skin’s top layer deteriorates, sheds, and begins healing over the course of several days. SJS represents a medical emergency often necessitating hospitalization. Treatment primarily revolves around identifying and discontinuing the causative agent, tending to wounds, managing pain, and reducing potential complications during the skin’s regeneration process. Recovery may span from weeks to months. A more severe variant known as toxic epidermal necrolysis…

Topiramate, classified within the anti-epileptic medication category, has received FDA approval for managing seizure disorders and mitigating migraines. However, a prevalent side effect associated with this drug is weight loss. Consequently, various studies have scrutinized Topamax to assess its potential effectiveness and safety in promoting weight loss. While Topamax is exclusively FDA-sanctioned for weight loss when coupled with another medication known as phentermine, this combined treatment is marketed under the brand name Qsymia. Although Topamax is occasionally utilized independently for weight loss, such usage is considered off-label. Despite its off-label status for weight loss, Topamax remains widely prescribed. According to…

Sulfonamides, also known as sulphonamides, represent a class of synthetic medications containing the sulfonamide chemical group and are commonly referred to as sulfa drugs. While many people use the term sulfonamide loosely to describe only antibiotics incorporating a sulfonamide functional group in their chemical makeup, there exist various non-antibiotic sulfonamides developed by leveraging insights gained from the clinical assessment of antibiotic sulfonamides. These non-antibiotic variants serve diverse purposes such as managing diabetes and alleviating pain. The initial sulfonamide, Sulfanilamide, was formulated in 1906, though its application as an antimicrobial agent didn’t occur until the late 1930s. Sulfonamide antimicrobials, which are…

Tardive dyskinesia (TD) is a condition characterized by involuntary and repetitive movements, typically affecting the face, trunk, and other body parts. TD often stems from the use of medications known as dopamine receptor blockers, such as antipsychotics and various prescription drugs. Studies suggest that a significant portion, ranging from 20% to 50%, of individuals taking antipsychotics may encounter TD, with women and older adults being particularly vulnerable. Prolonged use of dopamine receptor blockers can lead to alterations in the striatum, a region of the brain, which may contribute to the development of TD. However, it’s essential to understand that not…

Nabumetone, categorized as a nonsteroidal anti-inflammatory drug (NSAID), is utilized to alleviate pain and inflammation linked with conditions like osteoarthritis and rheumatoid arthritis. It is marketed under different brand names such as Relafen, Arthaxan, and Mebutan. Originating in the 1970s, Nabumetone was developed by the Spanish pharmaceutical company, Llorente. It received approval for use in the United States in 1991. Its mechanism involves the reduction of prostaglandin production, which are body chemicals contributing to pain and inflammation. Nabumetone stands out among NSAIDs as it is a prodrug, necessitating metabolism within the body to become active after oral consumption. Consequently, it…